Follow
Sanlorenzo Martina MD, PhD
Sanlorenzo Martina MD, PhD
Department of Medicine, Institute of Cancer Research, Medical University of Vienna
Verified email at meduniwien.ac.at
Title
Cited by
Cited by
Year
Pembrolizumab cutaneous adverse events and their association with disease progression
M Sanlorenzo, I Vujic, A Daud, A Algazi, M Gubens, SA Luna, K Lin, ...
JAMA dermatology 151 (11), 1206-1212, 2015
3472015
The risk of melanoma in airline pilots and cabin crew: a meta-analysis
M Sanlorenzo, MR Wehner, E Linos, J Kornak, W Kainz, C Posch, I Vujic, ...
JAMA dermatology 151 (1), 51-58, 2015
962015
The risk of melanoma in airline pilots and cabin crew: a meta-analysis
M Sanlorenzo, MR Wehner, E Linos, J Kornak, W Kainz, C Posch, I Vujic, ...
JAMA dermatology 151 (1), 51-58, 2015
962015
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
P Quaglino, M Maule, HM Prince, P Porcu, S Horwitz, M Duvic, R Talpur, ...
Annals of Oncology 28 (10), 2517-2525, 2017
912017
Melanoma immunotherapy
M Sanlorenzo, I Vujic, C Posch, A Dajee, A Yen, S Kim, M Ashworth, ...
Cancer biology & therapy 15 (6), 665-674, 2014
812014
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma
M Sanlorenzo, A Choudhry, I Vujic, C Posch, K Chong, K Johnston, ...
Journal of the American Academy of Dermatology 71 (6), 1102-1109. e1, 2014
782014
Favourable prognostic role of regression of primary melanoma in AJCC stage I–II patients
S Ribero, S Osella‐Abate, M Sanlorenzo, P Savoia, C Astrua, G Cavaliere, ...
British Journal of Dermatology 169 (6), 1240-1245, 2013
712013
Sentinel lymph node biopsy in thick-melanoma patients (N= 350): what is its prognostic role?
S Ribero, S Osella-Abate, M Sanlorenzo, E Balagna, R Senetta, MT Fierro, ...
Annals of Surgical Oncology 22 (6), 1967-1973, 2015
702015
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics
A Latorre, C Posch, Y Garcimartín, A Celli, M Sanlorenzo, I Vujic, J Ma, ...
Nanoscale 6 (13), 7436-7442, 2014
692014
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
I Vujic, M Sanlorenzo, C Posch, R Esteve-Puig, AJ Yen, A Kwong, ...
Oncotarget 6 (2), 969, 2015
642015
Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis
S Ribero, MR Gualano, S Osella-Abate, G Scaioli, F Bert, M Sanlorenzo, ...
JAMA dermatology 151 (12), 1301-1307, 2015
632015
Mycoplasma pneumoniae‐associated mucositis – case report and systematic review of literature
I Vujic, A Shroff, M Grzelka, C Posch, B Monshi, M Sanlorenzo, ...
Journal of the European Academy of Dermatology and Venereology 29 (3), 595-598, 2015
602015
Apremilast in psoriasis–a prospective real‐world study
I Vujic, R Herman, M Sanlorenzo, C Posch, B Monshi, K Rappersberger, ...
Journal of the European Academy of Dermatology and Venereology 32 (2), 254-259, 2018
552018
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years
S Osella‐Abate, S Ribero, M Sanlorenzo, MM Maule, L Richiardi, ...
International journal of cancer 136 (10), 2453-2457, 2015
522015
Combined inhibition of MEK and Plk1 has synergistic antitumor activity in NRAS mutant melanoma
C Posch, BD Cholewa, I Vujic, M Sanlorenzo, J Ma, ST Kim, S Kleffel, ...
Journal of Investigative Dermatology 135 (10), 2475-2483, 2015
472015
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
P Dapavo, I Vujic, MT Fierro, P Quaglino, M Sanlorenzo
Journal of the American Academy of Dermatology 75 (4), 736-739, 2016
382016
The risk of melanoma in pilots and cabin crew: UV measurements in flying airplanes
M Sanlorenzo, I Vujic, C Posch, JE Cleaver, P Quaglino, S Ortiz-Urda
JAMA dermatology 151 (4), 450-452, 2015
362015
Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients
C Posch, F Weihsengruber, K Bartsch, V Feichtenschlager, M Sanlorenzo, ...
British journal of cancer 110 (6), 1427-1432, 2014
312014
Mutant NRASQ61 shares signaling similarities across various cancer types–potential implications for future therapies
I Vujic, C Posch, M Sanlorenzo, AJ Yen, A Tsumura, A Kwong, ...
Oncotarget 5 (17), 7936, 2014
292014
Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells
L Gammaitoni, L Giraudo, M Macagno, V Leuci, G Mesiano, R Rotolo, ...
Clinical Cancer Research 23 (9), 2277-2288, 2017
282017
The system can't perform the operation now. Try again later.
Articles 1–20